Supplemental information for "Biomarkers predictive of severe complications and mortality in patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid: a retrospective longitudinal observational study"

Published: 7 April 2021| Version 1 | DOI: 10.17632/cfdv85gmv5.1
Contributors:
Yumi Aoyama,
,

Description

Contents: Supplemental Methods and Legends Supplemental Fig 1 Supplemental Fig 2 Supplemental Fig 3

Files

Categories

Biomarkers, Autoimmune Disorder, Retrospective Study, Immune Response, Adverse Effect of Drug, Bullous Disease

Licence